GC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats
- PMID: 21293480
- PMCID: PMC4009941
- DOI: 10.1038/aps.2010.196
GC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats
Abstract
Aim: To explore the alteration of endogenous metabolites and identify potential biomarkers using metabolomic profiling with gas chromatography coupled a time-of-flight mass analyzer (GC/TOF-MS) in a rat model of estrogen-deficiency-induced obesity.
Methods: Twelve female Sprague-Dawley rats six month of age were either sham-operated or ovariectomized (OVX). Rat blood was collected, and serum was analyzed for biomarkers using standard colorimetric methods with commercial assay kits and a metabolomic approach with GC/TOF-MS. The data were analyzed using multivariate statistical techniques.
Results: A high body weight and body mass index inversely correlated with serum estradiol (E2) in the OVX rats compared to the sham rats. Estrogen deficiency also significantly increased serum total cholesterol, triglycerides, and low-density lipoprotein cholesterol. Utilizing GC/TOF-MS-based metabolomic analysis and the partial least-squares discriminant analysis, the OVX samples were discriminated from the shams. Elevated levels of cholesterol, glycerol, glucose, arachidonic acid, glutamic acid, glycine, and cystine and reduced alanine levels were observed. Serum glucose metabolism, energy metabolism, lipid metabolism, and amino acid metabolism were involved in estrogen-deficiency-induced obesity in OVX rats.
Conclusion: The series of potential biomarkers identified in the present study provided fingerprints of rat metabolomic changes during obesity and an overview of multiple metabolic pathways during the progression of obesity involving glucose metabolism, lipid metabolism, and amino acid metabolism.
Figures




Similar articles
-
Metabolomic profiles delineate signature metabolic shifts during estrogen deficiency-induced bone loss in rat by GC-TOF/MS.PLoS One. 2013;8(2):e54965. doi: 10.1371/journal.pone.0054965. Epub 2013 Feb 7. PLoS One. 2013. PMID: 23408954 Free PMC article.
-
Global and untargeted metabolomics evidence of the protective effect of different extracts of Dipsacus asper Wall. ex C.B. Clarke on estrogen deficiency after ovariectomia in rats.J Ethnopharmacol. 2017 Mar 6;199:20-29. doi: 10.1016/j.jep.2017.01.050. Epub 2017 Jan 26. J Ethnopharmacol. 2017. PMID: 28132861
-
Metabonomic profiling in studying anti-osteoporosis effects of strontium fructose 1,6-diphosphate on estrogen deficiency-induced osteoporosis in rats by GC/TOF-MS.Eur J Pharmacol. 2013 Oct 15;718(1-3):524-32. doi: 10.1016/j.ejphar.2013.06.030. Epub 2013 Jul 16. Eur J Pharmacol. 2013. PMID: 23872379
-
Paediatric obesity: a systematic review and pathway mapping of metabolic alterations underlying early disease processes.Mol Med. 2021 Nov 6;27(1):145. doi: 10.1186/s10020-021-00394-0. Mol Med. 2021. PMID: 34742239 Free PMC article.
-
Estrogen Deprivation and Myocardial Infarction: Role of Aerobic Exercise Training, Inflammation and Metabolomics.Curr Cardiol Rev. 2020;16(4):292-305. doi: 10.2174/1573403X15666190729153026. Curr Cardiol Rev. 2020. PMID: 31362678 Free PMC article. Review.
Cited by
-
Metabolomics-driven identification of perturbations in amino acid and sphingolipid metabolism as therapeutic targets in a rat model of anorexia nervosa disease using chemometric analysis and a multivariate analysis platform.RSC Adv. 2020 Jan 29;10(9):4928-4941. doi: 10.1039/c9ra05187b. eCollection 2020 Jan 29. RSC Adv. 2020. PMID: 35498285 Free PMC article.
-
Effects of short- and long-term glucocorticoid-induced osteoporosis on plasma metabolome and lipidome of ovariectomized sheep.BMC Musculoskelet Disord. 2020 Jun 5;21(1):349. doi: 10.1186/s12891-020-03362-7. BMC Musculoskelet Disord. 2020. PMID: 32503480 Free PMC article.
-
Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats.Acta Pharmacol Sin. 2014 Oct;35(10):1265-73. doi: 10.1038/aps.2014.72. Epub 2014 Sep 15. Acta Pharmacol Sin. 2014. PMID: 25220639 Free PMC article.
-
Metabolomic profiles delineate signature metabolic shifts during estrogen deficiency-induced bone loss in rat by GC-TOF/MS.PLoS One. 2013;8(2):e54965. doi: 10.1371/journal.pone.0054965. Epub 2013 Feb 7. PLoS One. 2013. PMID: 23408954 Free PMC article.
-
Integrative Bone Metabolomics-Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model.Sci Rep. 2018 Nov 7;8(1):16456. doi: 10.1038/s41598-018-34574-6. Sci Rep. 2018. PMID: 30405156 Free PMC article.
References
-
- Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–209. - PubMed
-
- Ryan AS, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care. 2002;25:127–33. - PubMed
-
- Winter Y, Rohrmann S, Linseisen J, Lanczik O, Ringleb PA, Hebebrand J, et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke. 2008;39:3145–51. - PubMed
-
- Kirschner MA, Ertel N, Schneider G. Obesity, hormones, and cancer. Cancer Res. 1981;41:3711–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous